These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 7471473
1. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera. Weiss JJ, Meyers S, Castor CW, Donakowski C, Anderson B. Clin Chim Acta; 1980 Dec 22; 108(3):425-33. PubMed ID: 7471473 [Abstract] [Full Text] [Related]
2. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Castor CW, Miller JW, Walz DA. Proc Natl Acad Sci U S A; 1983 Feb 22; 80(3):765-9. PubMed ID: 6572368 [Abstract] [Full Text] [Related]
13. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor. Myers SL, Castor CW. Arthritis Rheum; 1980 May 01; 23(5):556-63. PubMed ID: 7378085 [Abstract] [Full Text] [Related]
14. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases. Car BD, Baggiolini M, Walz A. Biochem J; 1991 May 01; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437 [Abstract] [Full Text] [Related]
15. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, Kaplan AP. J Allergy Clin Immunol; 1992 Mar 01; 89(3):666-72. PubMed ID: 1372016 [Abstract] [Full Text] [Related]
16. Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III. Deutsch V, Bitan M, Friedmann Y, Eldor A, Vlodavsky I. Br J Haematol; 2000 Dec 01; 111(4):1180-9. PubMed ID: 11167759 [Abstract] [Full Text] [Related]
17. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. Baeza ML, Reddigari SR, Kornfeld D, Ramani N, Smith EM, Hossler PA, Fischer T, Castor CW, Gorevic PG, Kaplan AP. J Clin Invest; 1990 May 01; 85(5):1516-21. PubMed ID: 1692035 [Abstract] [Full Text] [Related]
18. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Brandt E, Van Damme J, Flad HD. Cytokine; 1991 Jul 01; 3(4):311-21. PubMed ID: 1873479 [Abstract] [Full Text] [Related]
19. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III. Castor CW, Walz DA, Johnson PH, Hossler PA, Smith EM, Bignall MC, Aaron BP, Underhill P, Lazar JM, Hudson DH. J Lab Clin Med; 1990 Oct 01; 116(4):516-26. PubMed ID: 2212861 [Abstract] [Full Text] [Related]
20. A possible receptor-binding function for the N-terminus of connective tissue activating peptide III. Erickson J, Davis LE, Castor CW, Walz DA, Anderson BE. Biochemistry; 1990 May 01; 29(17):4077-80. PubMed ID: 2141792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]